New Key Statistics Module, Z-Score and F-Score
OTCPK:NMLSF Key Ratios
Market Cap $ M | 1.08 |
Enterprise Value $ M | 1.65 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | -- |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -0.002 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | 17.30 |
5-y EBITDA Growth Rate % | 32.30 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -6.61 |
EV-to-EBITDA | -6.66 |
PEG | -- |
Shares Outstanding M | 148.32 |
Net Margin (%) | -1,171.43 |
Operating Margin % | -1,203.57 |
Pre-tax Margin (%) | -1,171.43 |
Quick Ratio | 0.03 |
Current Ratio | 0.03 |
ROA % (ttm) | -304.64 |
ROE % (ttm) | -- |
ROIC % (ttm) | -1,053.13 |
Dividend Yield % | -- |
Altman Z-Score | -2,265.91 |
NMLSF Number of Guru Trades
NMLSF Volume of Guru Trades
Gurus Latest Trades with OTCPK:NMLSF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:NMLSF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Nova Mentis Life Science Corp Insider Transactions
No Available Data
News about OTCPK:NMLSF
Total 0- 1